September 22nd, 2013
Join the conversation launched by The New England Journal of Medicine and Harvard Business Review about the future of health care innovation.
December 22nd, 2011
Last week, CardioMEMS failed to get approval from an FDA advisory panel for treating heart failure based on uncertainty regarding the benefit; the advisory panel also raised concerns about study bias. This intracardiac device measures pulmonary artery pressures that clinicians can use (in addition to other clinical signals, such as weight gain) to select therapies […]